|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-7-16
|
|
pubmed:abstractText |
A nephrotic patient with membranoproliferative glomerulonephritis type II (MPGN II) was treated with cyclosporin A (CSA) and alternate-day low-dose prednisolone. This patient developed the nephrotic syndrome twice. The second episode of the nephrotic syndrome was steroid resistant, and therefore this patient was treated with a CSA regimen. During treatments with alternate-day low-dose prednisolone and CSA, this patient recovered from the nephrotic syndrome. We conclude that CSA therapy may be effective for patients with the steroid-resistant nephrotic syndrome caused by MPGN II.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0028-2766
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
91
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
509-11
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12119488-Child,
pubmed-meshheading:12119488-Complement C3,
pubmed-meshheading:12119488-Cyclosporine,
pubmed-meshheading:12119488-Glomerular Mesangium,
pubmed-meshheading:12119488-Glomerulonephritis, Membranoproliferative,
pubmed-meshheading:12119488-Glucocorticoids,
pubmed-meshheading:12119488-Humans,
pubmed-meshheading:12119488-Immunosuppressive Agents,
pubmed-meshheading:12119488-Japan,
pubmed-meshheading:12119488-Male,
pubmed-meshheading:12119488-Prednisolone
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Cyclosporin A treatment for membranoproliferative glomerulonephritis type II.
|
|
pubmed:affiliation |
Department of Pediatrics, Kyoto National Hospital, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan. tkiyomas@kyotolan.hosp.go.jp
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
